| Identification |
| Name: | Morphinan-6-one,4,5-epoxy-3,14-dihydroxy-17-(2-propen-1-yl)-, 2-[(5a)-4,5-epoxy-3,14-dihydroxy-17-(2-propen-1-yl)morphinan-6-ylidene]hydrazone |
| Synonyms: | Morphinan-6-one,4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, [(5a)-4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-ylidene]hydrazone,(5a)- (9CI); NIH 10894; NSC 612113;Naloxonazine |
| CAS: | 82824-01-9 |
| Molecular Formula: | C38H42 N4 O6 |
| Molecular Weight: | 723.69 |
| InChI: | InChI=1/C38H42N4O6/c1-3-15-41-17-13-35-29-21-5-7-25(43)31(29)47-33(35)23(9-11-37(35,45)27(41)19-21)39-40-24-10-12-38(46)28-20-22-6-8-26(44)32-30(22)36(38,34(24)48-32)14-18-42(28)16-4-2/h3-8,27-28,33-34,43-46H,1-2,9-20H2/b39-23-,40-24- |
| Molecular Structure: |
 |
| Properties |
| Density: | 1.58g/cm3 |
| Refractive index: | 1.791 |
| Biological Activity: | Potent opioid antagonist, selective for μ 1 receptors. |
| Storage Temperature: | −20°C |
| Color: | off-white to light tan |
| Safety Data |
| |
 |
